Genetic Analysis Systems Enter the Clinical Mainstream
... software packages support sequencing analysis and gene mapping. The optional MicroSeq software package supports comparison of the sequence of unidentified bacteria or fungi with a validated library for positive identification and taxonomic classification. Cepheid, Sunnyvale, Calif., is introducing the Ge...The Past, Present and Future of HLA Typing
...ind the complementary polymorphism and amplify the gene segment, then the PCR product can be detected by standard techniques. If the primer is not complementary to the polymorphism, then it cannot bind and facilitate amplification: no PCR product is present. By constructing an array of PCR primers compl...Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
...edge to patient care. Probably the most important gene family to govern individual drug responses, CYP (a.... The first step is to amplify CYP2D6 and CYP2C19 gene products, which are then applied to the AmpliChip microarray and hybridized. The microarray is then......bal markets, integrating device design, biopharma, gene andcell therapy and biotech to enhance patient safety and improveclinical outcomes. Cook won the prestigious Medical DeviceManufacturer of the Year for 2006 from Medical Device andDiagnostic Industry magazine. For more information, visitwww.cookmedic......molecularly engineeredtherapy selectively embeds a gene in pancreatic cancer that shrinksor eradicates tum..., also called apromoter, two components that boost gene expression in the targettissue, and a payload - in this case a gene known to kill cancercells. It's ...Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
...gy company engaged in the development ofinnovative gene therapies for the brain and central nervous system...s ofthe brain and central nervous system utilizing gene therapies. TheCompany's initial development efforts are focused on gene therapyfor treating Parkinso......-based chemotherapydepending on whether the ERCC-1 gene expression in their tumorsample was above or below a specific threshold. Patients wereassigned to one of two arms in this trial. The control armconsisted of all patients receiving cisplatin-based therapy.Patients in the "genotypic" arm were separated...Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
...er, and closeto half of all human tumors carry p53 gene mutations within theircells. As a transcription factor, p53 can increase or repress thetranscription of many hundreds of protein-encoding genes, and thisability is believed to underlie in great part its tumor suppressorfunctions. About microRNAs Mi......chers found that animalmodels in which the ANGPTL4 gene was knocked out had lowertriglyceride and cholesterol levels than normal animals. TheANGPTL4 gene encodes a protein that is secreted into thebloodstream and is now believed to play an important role...Researchers Discover Method for Identifying How Cancer Evades the Immune System
...vior. Using real-time PCR (rtPCR), a high-speed gene amplificationtechnique, Epstein and his M.D./ Ph.D...on of immune cells, andover-production of B7-H4, a gene whose protein product inhibitsimmune activation. The human colorectal cancers, however, showedvariat...Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
...and destroy tumors like tiny homing missiles. This gene therapy approach is a novel way to attack smalltum...ory andthen used a retrovirus vector to insert the gene cytosine deaminaseinto the cell. This gene can convert a less toxic drug, 5-fluorocytosine (5-FC), t......d hotline,and operates Bank On A Cure(R), a unique gene bank to advancemyeloma research. The IMF can be reached at (800) 452-CURE or<a target="_blank" href="http://www.myeloma.org/">http://www.myeloma.org , and inSpanish at <a target="_blank" href="http://www.myelomala.org/">http://www.mye...Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
...fying biological pathways is through studies ofthe gene mutations and variations involved in different types ofneuroblastoma, and Maris's team is calling on the sophisticatedgene-hunting facilities at the new Center for Applied Genomics atChildren's Hospital to advance that knowledge. "Our goal is to mat......F(TM)) designed to upregulate theexpression of the gene encoding vascular endothelial growth factor(VEGF-A...al therapeutic programs -- modification ofthe CCR5 gene in human primary T-cells for the treatment ofHIV/AIDS and a novel therapy for the treatment of gliob...Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
...tified EP3 as a targetby isolating variants in the gene encoding the EP3 receptor forprostaglandins E2 (PG...geted by aspirin and Plavix(TM). FollowingdeCODE's gene discovery, work by leading international scientistshas demonstrated in mice that PGE2 is produced in...Researchers Discover Gene For Rare Skin Disorder
...eNational Institutes of Health have identified the gene thataccounts for most cases of Goltz syndrome, a r...t. The cases appear to result from a defect in the gene known asPORCN, which contains the information needed to make a protein,referred to by researchers as...GenoLogics Announces Bioinformatics Partnership with Illumina
...ions to our technology platforms forgenotyping and gene expression applications." ?I am very excited ab...e, BeadStudio, which will enable ourcustomers with gene expression and genotyping applications to tietheir data together using one integrating LIMS system. ...... Parkinson's disease and the first report ofdirect gene transfer into a patient's own brain cells for any ...trated both a lack of adverseevents related to the gene therapy procedure and statisticallysignificant improvements from baseline in both clinical symptomsa...Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
...ient samples which showa correlation of changes in gene expression in a dose dependentmanner. Importantly,... thesehigher levels, including members of the Bcl2 gene family which playa critical role in programmed cell death. Additionally, the IMPDHenzyme is inhibite...Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
... The treatment uses Vical technology to deliver a gene encodingHepatocyte Growth Factor (HGF), a human protein that causesangiogenesis (growth of blood vessels) in areas of ischemia(restricted blood flow). In the trial, 40 subjects with criticallimb ischemia (advanced peripheral arterial disease) were ev......s hESC platform. Otherpresentations focused on the gene expression and neurotrophicprotein secretion patterns of hESC-derived oligodendroglialprogenitor cells for acute spinal cord injury, the functionalcharacterization of hESC-derived islets for diabetes, andhESC-derived chondrocytes for arthritis and ot......oranti-cancer drugs. Knock-down of VDAC2 and VDAC3 gene expressioncauses resistance to erastin, implicating the involvement of thesetwo proteins in erastin-mediated cell death. Treatment of cellswith erastin results in VDAC-protein-mediated mitochondrialdysfunction, release of oxidative species and, ultim...Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
...t to deliver genes that encode proteins toincrease gene function or RNAi to decrease or silence genefunction. Targeted Genetics´ product development effortstarget inflammatory arthritis, AIDS prophylaxis, congestive heartfailure and Huntington´s disease. To learn more aboutTargeted Genetics, v......ollowing partial surgicalremoval. By comparing the gene expression profiles of endothelialcells from regen...giogenesis. Among the genesidentified was CD276, a gene that encodes a protein located on thecell surface, as well as other known and previously undescribed......bined inNeuroVax(TM) correspond to one or more TCR gene families which areover expressed in 90% of MS patients. Previous clinical trialsconducted by the Company and other independent researchers haveassociated diminished levels of Foxp3+ Treg responses with thepathogenesis and progression of MS. This same...Studies Show Efficacy and Safety of Alexion's Soliris in Broad Population of PNH Patients
...en P. Paroxysmal nocturnal hemoglobinemia:Nature's gene therapy? J Clin Path: Mol Pathol.2002;55:145-152. 10 Wang, et al. Clinical significance of a minor population ofparoxysmal nocturnal hemoglobinuria-type cells in bone marrowfailure syndrome. Blood 2002;100:3897-3902. 11 Iwanga, et al. Paroxysmal no...Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
...dthat deletion of the ubiquitously expressed Rpl22 gene resulted inthe up-regulation of p53, a key tumor suppressor gene that triggersapoptosis and cell death. Further, it was determined that thisup-regulation of p53 was ...Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
...ue at least in part to over expression ofthe Bcl-2 gene characteristic of the disease. About Bcl-2 The p...tfolio of novel experimental drugsblocking harmful gene expression being designed and developed bySantaris Pharma. The drug belongs to a new class of drugs ......lective tissuedistribution with minimal effects on gene expression inextra-hepatic tissues. The studies in rats and mice showed animproved safety profile, including no cardiac effects and reducedeffects on the thyroid hormone axis compared to KB-141. The second poster provides data showing that oral ad...Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
... ofgene expression. Epigenetic changes can silence gene expressionand, unlike DNA mutations, may be revers...ediate histone deacetylation,an epigenetic form of gene regulation that may silence tumorsuppressor genes, thereby promoting tumor growth. MGCD0103 is anora......pression in normal cells.Expression of the MAGE A3 gene has been observed in testicularcells but without antigen presentation capabilities. MAGE-A3 antigen has been in-licensed by GSK from the LudwigInstitute for Cancer Research, the largest international academicinstitute dedicated to understanding and ......finitive benchmark in the emerging field of cancer gene therapy.The first clinical report of its kind, Le ...ance cancersurvival, the potential of an auxiliary gene transfer strategy wasexplored, specifically intended to induce cancer auto-immunization.This immuniz......d hotline,and operates Bank on a Cure(R), a unique gene bank to advancemyeloma research. The IMF can be reached at 818-487-7455. Theglobal Website is <a target="_blank" href="http://www.myeloma.org/">www.myeloma.org with a companionWebsite in Spanish at <a target="_blank" href="http://www.mye......adefined patient subgroup with the methylated MGMT gene promoter inthe tumor tissue, 91% of patients had s...s PFS, median PFS of 6.9months;(1) methylated MGMT gene promoter subgroup: 69% PFS and 10.3months median PFS].(2) Lead investigator Dr. Roger Stupp of th......mersubsidiary, Ceregene, Inc., which is developing gene therapies forneurodegenerative disorders. Cell Genesys is headquartered in SouthSan Francisco, CA and has its principal manufacturing operation inHayward, CA. For additional information, please visit the company'swebsite at <a target="_blank" hre...Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
...en P. Paroxysmal nocturnal hemoglobinemia:Nature's gene therapy? J Clin Path: Mol Pathol.2002;55:145-152. (4) Wang, et al. Clinical significance of a minor population ofparoxysmal nocturnal hemoglobinuria-type cells in bone marrowfailure syndrome. Blood 2002;100:3897-3902. (5) Iwanga, et al. Paroxysmal ...... function of HER2, a proteinproduced by a specific gene with cancer-causing potential. It hasdemonstrated efficacy in treating both early and advanced(metastatic) breast cancer. Given on its own as monotherapy as wellas in combination with or following standard chemotherapy,Herceptin has been shown to imp......n with radiation therapy in solid tumors. Themda-7 gene is the active component of INGN 241 and was discoveredin the laboratory of Dr. Paul B. Fisher, professor of clinicalpathology at Columbia University. Introgen holds an exclusiveworldwide sublicense to the Columbia University rights for all genetherap......Therapeutics (AMT), a leader in the field of human gene therapy,reported positive Phase I/II clinical tria...sent an important milestone for the entire fieldof gene therapy and for the many patients who today cannot betreated. Our clinical success and the breakthro......ed withincreased survival following adenoviral p53 gene therapy (ADVEXIN)in patients with recurrent squamous cell carcinoma of the head andneck, Abstract #6057: Poster presentation on Mon., June 4, from1:00 - 5:00 p.m. at McCormick Place by lead author John Nemunaitis,M.D., Mary Crowley Medical Research C......tion technology wassafe and tolerable, facilitated gene expression, and resulted insignificant objective t...ased IL-12 with electroporation.These data confirm gene expression in the treated subjects. Inaddition, initial evaluation determined that nearly 70 percent...Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
...xidoreductase(WWOX), an important tumor suppressor gene with known involvementin breast, prostate, lung, pancreatic, esophageal, and gastriccancers. The peer-reviewed article was published in the onlineedition (25 April 2007) of the Journal of Cellular Physiology as aMini Review entitled "WWOX in biologic...Inovio: DNA delivery technology shows positive human results
...and, in the case of DNA-based treatments, levelsof gene expression. Inovio’s DNA delivery partners i...o our plansto develop our electroporation drug and gene delivery technology.Actual events or results may differ from our expectations as aresult of a number......y'sproprietary labeling and detection products for gene sequencing andgenetic analysis are sold to the life sciences market throughoutthe world. Enzo Biochem owns or licenses over 200 patentsworldwide. Except for historical information, the matters discussed in thisnews release may be considered "forward...Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
...nd, in the case of gene-based treatments, levelsof gene expression. Inovio's technology is protected by anextensive patent portfolio covering in vivo electroporation. Moreinformation is available at www.inovio.com. This press release contains certain forward-looking statementsrelating to our plans to dev...The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
...d hotline,and operates Bank on a Cure(R), a unique gene bank to advancemyeloma research. The IMF can be reached at 818-487-7455. Theglobal Website is <a target="_blank" href="http://www.myeloma.org/">http://www.myeloma.org with acompanion Website in Spanish at <a target="_blank" href="http://...GenVec Presents Research on New Ad35 Adenovector at ARVO
...uchtherapeutics. A possible strategy is the use of gene deliverysystems to achieve sustained production of...jected every four to six weeks. GenVecbelieves its gene transfer approach may provide an effective andmore convenient treatment for AMD. About GenVec GenV......transcription factors(ZFP TF(TM)) that can control gene expression and, consequently,cell function. Sangam...ce-specific ZFPNucleases (ZFN(TM)) for therapeutic gene modification as atreatment for a variety of monogenic diseases, such as X-linkedSCID and hemophilia,......fectedparent having a 50% chance of inheriting the gene that causes HD.The disease does not skip generations, and everyone who carries thegene will develop the disease. Most people with HD develop theillness between the ages of 30 and 45. At this time, there is noway to stop, slow or reverse the course of...Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
...m clinical data from a Phase 1 trial ofCERE-110, a gene therapy product designed to deliver nerve growthfa...E-110-NGF administered by anadeno-associated viral gene delivery system-could be safelydelivered. All six patients enrolled in the study underwentstereotact...Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
.... Other projects comprise drug development within gene therapyusing the exclusively licensed and patent p... Delivery System (NTDDS). The company’s lead gene therapyprojects include using Enkephalin and GAD for chronic pain, e.g.,diabetes pain or cancer pain...Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
...heir clonal selection andexpansion, however, their gene and protein expression patternschange significantly, thereby losing many of their primarycharacteristics. Primary cell cultures are useful tools becausethey better reflect the molecular reality in tumors. A previousIndivumed study, however, showed th......rapeutics BV (AMT), a leader in the field of human gene therapy,will today present preclinical data on its AMT-020 gene therapy totreat acute intermittent porphyria (AIP) at the Porphyrins andPorphyrias Congress, Rotterd...Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
...slie in or near: · IGF2BP2. This gene codes for a protein called insulin-like growthfact...test study found thatvariations in or near the FTO gene are also associated with greaterrisk of type 2 diabetes, which is likely related to an increasedpred......n with radiation therapy in solid tumors. Themda-7 gene is the active component of INGN 241 and was discoveredin the laboratory of Dr. Paul B. Fisher, professor of clinicalpathology at Columbia University. Introgen holds an exclusiveworldwide sublicense to the Columbia University rights for all genetherap...Cortex Area Thinner in Youth with Alzheimers-Related Gene
...h.gov/Alzheimers/ )is thinner in youth with a risk gene for the disorder, a brainimaging study by research...ity colleagues. They report on how variationin the gene for apoliproprotein (ApoE), which plays a critical rolein repair of brain cells, affects development...Gentium's Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
... has an effect on the down-regulation ofheparanase gene expression, but also decreases its enzymaticactivi...ppressed in vitro both theexpression of heparanase gene and heparanase enzymatic activity inmultiple myeloma tumor cell lines. Consequently, this studyaddre...Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets
...ng protein encoded by the disrupted gene.Lexicon's gene knockout technology is being employed in theCompan...ivedisorders. The company has used its proprietary gene knockouttechnology to discover more than 100 promising drug targets andcreate an extensive pipeline ......studies identified a novelspliced variant of SPARC gene that differed from known human SPARCmRNA sequence by a single amino acid residue. Although the role ofthis form of SPARC is still under investigation, the existence ofthis spliced variant in human may explain the evolution biology ofSPARC and enhance...... Othera scientists, Dr. Mousa performedlarge-scale gene expression studies using microchip arrays thatprovided evidence of OT-551's effect on several human inflammatorygenes regulated by NF-kB. Subsequent animal studies confirmed thatOT-551 treatment reduces levels of TNF-(alpha), a key inflammatorycytoki...